Publications in collaboration with researchers from Ohio State University Wexner Medical Center (2)

2021

  1. Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer

    Annals of Oncology, Vol. 32, Núm. 9, pp. 1148-1156

  2. Sacituzumab govitecan in metastatic triple-negative breast cancer

    New England Journal of Medicine, Vol. 384, Núm. 16, pp. 1529-1541